Prolactin response to acute administration of different L-dopa plus decarboxylase inhibitors in Parkinson's disease. 1982

S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli

Plasma prolactin (PRL) levels modifications after acute administration of L-dopa, L-dopa plus carbidopa and L-dopa plus benserazide were studied in parkinsonian patients. PRL increase after benserazide was compared with PRL response after carbidopa at the same dosage in untreated parkinsonian patients. A further study of the hyperprolactinemic effect of benserazide was performed in vitro on isolated and dispersed rat pituitary cells. The data gathered indicate that benserazide-induced hyperprolactinemia in parkinsonian patients could be due to a direct effect of the drug at the hypothalamic level and consequently to an inhibition of dopamine decarboxylation in the tuberoinfundibular dopaminergic system. It is not possible to exclude, however, that benserazide could exert its biological activity through the production of active metabolites in vivo.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D002230 Carbidopa An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself. Methyldopahydrazine,Carbidopa, (R)-Isomer,Carbidopa, (S)-Isomer,Lodosin,Lodosyn,MK-485,MK-486,MK 485,MK 486,MK485,MK486
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
January 1972, Zeitschrift fur Neurologie,
S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
February 2014, Parkinsonism & related disorders,
S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
May 1979, Wiener klinische Wochenschrift,
S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
February 1974, Ugeskrift for laeger,
S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
March 1974, La Revue du praticien,
S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
January 1975, Acta neurologica Belgica,
S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
September 1970, Lancet (London, England),
S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
June 1973, Nature,
S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
January 1971, La Presse medicale,
S Ruggieri, and P Falaschi, and M Baldassarre, and R D'Urso, and G De Giorgio, and A Rocco, and A Agnoli
January 1972, Zeitschrift fur Neurologie,
Copied contents to your clipboard!